Stallion India Fluorochemicals Q1 FY27 Concall Summary
Note : AI genereated summary using transcript. Caution needed.
1. Q1 FY27 financial performance
The numbers were very strong:
₹ crore Q1 FY27 YoY growth
Revenue 124.68 +12.78%
EBITDA 25.27 +75.85%
PAT 18.57 +79.15%
EBITDA margin ~20.3% Significant improvement
PAT margin ~14.9% Significant improvement
Management attributed the exceptional profitability to a combination of: better product mix, higher HFO contribution, better inventory planning, logistics planning, inventory accumulated before the Gulf-related disruption, pricing benefits during the supply/logistics disruption.
Importantly, management explicitly said the EBITDA improvement was roughly 50% from better business/product mix and 50% from inventory-related benefits.
2. The biggest positive: 30–35% growth guidance remains intact
Despite the R32 plant being delayed, management reconfirmed 30–35% revenue CAGR for three years.
FY27 R32 contribution will be lower, but the overall 3-year growth strategy remains intact.
3. R32 plant – delay is disappointing, but economics remain attractive
This is probably the biggest issue emerging from the call. Earlier commissioning expectation: around July/October 2026. Now: targeting December 2026
Management explained the delay primarily through the delay in raising funds.
They had initially planned a preferential issue, but because of the sharp movement in the share price, that route didn’t happen. They subsequently went through the rights issue route, with funds coming later than originally planned.
FY27 impact
The earlier presentation had indicated approximately ₹250 crore FY27 revenue contribution from R32.
Management now acknowledged that ₹250 crore will reduce to roughly ₹125 crore because commissioning has moved to December.
Management reconfirmed approximately ₹500–600 crore annual revenue potential from the R32 plant in FY28.
4. R32 economics look attractive
Current R32 market price was indicated at around ₹800/kg versus approximately ₹900/kg at the peak. Management stressed that Stallion’s project calculations were not based on peak R32 prices. They used conservative assumptions, around ₹550/kg, for project feasibility.
If R32 prices fall from ₹800 toward ₹550–600, the project economics should still work according to management’s assumptions.
5. R32 could materially improve margins
Management indicated that the new manufacturing business could have approximately 24% PAT margin, compared with roughly 10% PAT margin for the conventional business.
Therefore, as the business mix shifts toward manufacturing, PAT and EBITDA margins should progressively improve.
6. Helium plant is now operational
The high-purity helium plant at Kalapur has 1,200 MT/year installed capacity.
Management said the plant has completed final checks and is operational, with helium revenue expected to begin in Q2 FY27.
The ramp-up will be gradual. The management also indicated that next-year utilisation could be around 20%, rather than 50%.
7. Helium pricing is extremely interesting
Current helium pricing at approximately ₹4,000/kg. Prices have risen sharply and are currently stable at the new higher level.
Management expects the helium market to remain tight:
> shortfall + higher pricing over the next 2–3 years
The company is therefore entering helium at a potentially favourable time.
However, the key constraint isn’t demand. The constraint is availability.
Management repeatedly highlighted that selling helium isn’t the difficult part; securing supply is. They have therefore created sourcing arrangements and strategic relationships to reduce supply risk.
8. Gulf crisis / Middle East disruption – risk appears manageable
Because helium sourcing has Middle East exposure, analysts asked what happens if shipping disruption continues.
Management explained that they are using multiple suppliers, swapping arrangements, strategic sourcing, and alternate geographical sources.
Management said that pricing would probably increase, but availability should be less severely affected because of the sourcing arrangements.
But it also means helium margins could potentially benefit from higher prices if Stallion can secure sufficient supply.
9. Mambattu facility – much more than originally planned
Management expects Mambattu to become operational around the same broad timeframe as the R32 plant.
Mambattu by itself may not create an enormous revenue jump. Its strategic importance is that it becomes a complementary infrastructure platform for the R32/HFO business.
Management specifically said the strength of Mambattu comes when the R32 plant is operational.
10. HFO is the next major growth leg
Management indicated that HFO manufacturing is the next major project after R32.
The proposed capacity discussed: 10,000 tonnes — effectively 5,000 + 5,000 tonnes.
Current HFO pricing was indicated at approximately:
₹3,000–4,000/kg.
Management expects HFO manufacturing to have a significant positive impact on EBITDA and PAT.
And unlike Mambattu, HFO manufacturing can materially increase revenue over time.
11. Potential peak revenue is now very interesting
Management indicated eventual revenue potential of >₹1,100 crore once the major new businesses are operational with ~15% PAT margin at that scale.
This is obviously not a forecast for FY27/FY28, but rather management’s longer-term ambition.
If achieved: ₹1,100 crore revenue × 15% PAT ≈ ₹165 crore PAT versus FY26 PAT of approximately ₹43.8 crore.
FY26 itself was already strong, with revenue of ₹434.1 crore, EBITDA ₹61.35 crore and PAT ₹43.84 crore.
So the potential earnings trajectory is substantial.
12. Capital requirement – a new risk has emerged
Previously management had indicated that it preferred not to dilute equity and would use internal accruals + debt + operating cash flow for future expansion.
The position has now softened.
Management said that if Stallion wants to pursue its growth plans at a very fast pace, it may need additional capital.
The options could include:
some debt + some equity dilution.
Management has not decided to raise capital yet, but they have become open to dilution.
Why?
Because the company wants to potentially build approximately one plant every year for the next three years. Using only internal accruals would potentially stretch the expansion timeline from around 3 years to 6 years.
This creates an interesting trade-off for shareholders
There are two possible paths:
Scenario A — Conservative
Internal accruals + moderate debt
→ slower expansion
→ lower dilution
→ potentially better per-share economics
Scenario B — Aggressive
Debt + equity capital
→ faster HFO/other capacity creation
→ faster revenue growth
→ potentially higher absolute PAT
→ but share dilution
Management appears increasingly inclined toward Scenario B if necessary to maintain the aggressive growth trajectory.
Overall assessment of the call
Positives
1. Q1 profitability was excellent
PAT +79% and EBITDA +76%.
2. 30–35% revenue CAGR guidance maintained
Despite the R32 delay.
3. R32 project remains economically viable
Even at substantially lower prices than the current market.
4. R32 FY28 potential remains ₹500–600 crore
This is potentially transformational.
5. Helium has started
Revenue should begin from Q2.
6. Helium pricing is attractive
~₹4,000/kg currently.
7. Mambattu has become strategically more capable
12 tanks and multiple specialty-gas applications.
8. HFO manufacturing is now clearly emerging as the next major growth project.
9. Long-term target >₹1,100 crore revenue and ~15% PAT margin
Potentially very significant.
Things I would NOT extrapolate
Q1 EBITDA margin of ~20%
I would not use this as a sustainable FY27 margin.
Inventory gains and unusually favourable logistics contributed materially.
Management itself said this was a special quarter.
Risks to monitor
- R32 commissioning risk
- Working capital
- Possible equity dilution
- Helium sourcing
- HFO execution
- R32 price volatility
- Execution complexity of simultaneously moving into several new businesses.
